Histologic and Clinical Factors Associated with Kidney Outcomes in IgA Vasculitis Nephritis

Author:

Barbour Sean J.12,Coppo Rosanna3ORCID,Er Lee2,Pillebout Evangeline4ORCID,Russo Maria Luisa3,Alpers Charles E.5ORCID,Fogo Agnes B.6,Ferrario Franco7,Jennette J. Charles8ORCID,Roberts Ian S.D.9,Cook H. Terence10,Ding Jie11ORCID,Su Baige11,Zhong Xuhui11,Fervenza Fernando C.12ORCID,Zand Ladan12ORCID,Peruzzi Licia13ORCID,Lucchetti Laura14ORCID,Katafuchi Ritsuko15,Shima Yuko16ORCID,Yoshikawa Norishige17,Ichikawa Daisuke18ORCID,Suzuki Yusuke19ORCID,Murer Luisa20,Wyatt Robert J.21,Park Catherine21,Nelson Raoul D.22,Narus JoAnn H.23ORCID,Wenderfer Scott2425ORCID,Geetha Duvuru26ORCID,Daugas Eric2728ORCID,Monteiro Renato C.29ORCID,Nakatani Shinya30,Mastrangelo Antonio31,Nuutinen Matti3233,Koskela Mikael34,Weber Lutz T.35ORCID,Hackl Agnes35,Pohl Martin36,Pecoraro Carmine37,Tsuboi Nobuo38ORCID,Yokoo Takashi39ORCID,Takafumi Ito40,Fujimoto Shouichi41ORCID,Conti Giovanni42ORCID,Santoro Domenico43,Materassi Marco44ORCID,Zhang Hong45,Shi Sufang46ORCID,Liu Zhi-Hong47ORCID,Tesar Vladimir48ORCID,Maixnerova Dita49ORCID,Avila-Casado Carmen50,Bajema Ingeborg51,Barreca Antonella52ORCID,Becker Jan U.53,Comstock Jessica M.54,Cornea Virgilius55ORCID,Eldin Karen56ORCID,Hernandez Loren Herrera57,Hou Jean58,Joh Kensuke59ORCID,Lin Mercury58,Messias Nidia60,Muda Andrea Onetti61ORCID,Pagni Fabio7ORCID,Diomedi-Camassei Francesca62ORCID,Tokola Heikki63ORCID,D'Armiento Maria64,Seidl Maximilian65ORCID,Rosenberg Avi66ORCID,Sannier Aurélie67ORCID,Soares Maria Fernanda9ORCID,Wang Suxia68ORCID,Zeng Caihong47ORCID,Haas Mark58

Affiliation:

1. Division of Nephrology, University of British Columbia, Vancouver, British Columbia, Canada

2. BC Renal, Vancouver, British Columbia, Canada

3. Fondazione Ricerca Molinette, Regina Margherita Hospital, Turin, Italy

4. Nephrology Unit, Saint Louis Hospital, Paris, France

5. Department of Laboratory Medicine and Pathology, University of Washington Medical Center, Seattle, Washington

6. Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee

7. Department of Medicine and Surgery, IRCCS San Gerardo, University Milan Bicocca, Monza, Italy

8. Department of Pathology and Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina

9. Department of Cellular Pathology, Oxford University Hospitals NHS FT, Oxford, United Kingdom

10. Imperial College London, London, United Kingdom

11. Department of Pediatrics, Peking University First Hospital, Beijing, China

12. Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota

13. Pediatric Nephrology Unit, Regina Margherita Children's Hospital, AOU Città della Salute della Scienza di Torino, Turin, Italy

14. Division of Nephrology, Bambino Gesù Children's Hospital–IRCCS, Rome, Italy

15. Kidney Unit, National Hospital Organization Fukuokahigashi Medical Center, Fukuoka, Japan

16. Department of Pediatrics, Wakayama Medical University, Wakayama, Japan

17. Clinical Research Center, Takatsuki General Hospital, Wakayam Medical University, Takatsuki City, Japan

18. Division of Nephrology and Hypertension, Department of Internal Medicine, St. Marianna University School of Medicine, Kanagawa, Japan

19. Department of Nephrology, Juntendo University Faculty of Medicine, Tokyo, Japan

20. Pediatric Nephrology Dialysis and Transplant Unit, Department of Women's and Child's Health, Azienda Ospedaliera-University of Padova, Padua, Italy

21. Department of Pediatrics, University of Tennessee Health Sciences Center, Memphis, Tennessee

22. Division of Pediatric Nephrology, Department of Pediatrics, University of Utah, Salt Lake City, Utah

23. Pediatrics Clinical Trials Office, University of Utah, Salt Lake City, Utah

24. Division of Pediatric Nephrology, University of British Columbia, Vancouver, British Columbia, Canada

25. Texas Children's Hospital, Houston, Texas

26. Department of Medicine, Division of Nephrology, Johns Hopkins University School of Medicine, Baltimore, Maryland

27. Nephrology, Bichat Hospital, AP-HP, Paris, France

28. INSERM U1149 and Université Paris Cité, Paris, France

29. Centre for Research on Inflammation, Bichat Hospital, Inserm and Université Paris Cité, Paris, France

30. Department of Metabolism, Endocrinology and Molecular Medicine, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan

31. Pediatric Nephrology, Dialysis and Transplant Unit, Fondazione IRCC Ca’ Granda-Ospedale Maggiore Policlinico, Milan, Italy

32. Department of Children and Adolescents, Oulu University Hospital, Oulu, Finland

33. PEDEGO Research Unit, Research Unit for Pediatrics, Dermatology, Clinical Genetics, Obstetrics and Gynecology, Medical Research Center Oulu (MRC Oulu), Oulu, Finland

34. Department of Pediatric Nephrology and Transplantation, New Children's Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland

35. Pediatric Nephrology, Faculty of Medicine and University Hospital Cologne, Children's and Adolescents' Hospital, University of Cologne, Cologne, Germany

36. Medical Center, Department of General Pediatrics, Adolescent Medicine and Neonatology, Faculty of Medicine, University of Freiburg, Freiburg, Germany

37. Comitato Tecnico Scientifico per la Ricerca e Innovaziione, A.O. Santobono-Pausilipon, Naples, Italy

38. Division of Nephrology and Hypertension, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan

39. Department of Nephrology and Hypertension, Jikei University School of Medicine, Tokyo, Japan

40. Kidney Center, Department of Internal Medicine, Nephrology, Teikyo University School of Medicine, Teikyo University Chiba Medical Center, Chiba, Japan

41. Division of Dialysis, Department of Nephrology, University of Miyazaki Hospital, Miyazaki, Japan

42. Pediatric Nephrology and Rheumatology Unit, AOU Policlinic G Martino, University of Messina, Messina, Italy

43. Nephrology and Dialysis Unit AOU, G. Martino, University of Messina, Messina, Italy

44. Nephrology and Dialysis Unit, Meyer Children's Hospital, Florence, Italy

45. Renal Division, Peking University First Hospital, Beijing, China

46. Kidney Division, Department of Medicine, Peking University First Hospital, Peking University Institute of Nephrology, Beijing, China

47. National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China

48. Department of Nephrology, 1st Faculty of Medicine and General University Hospital, Charles University, Prague, Czech Republic

49. Department of Nephrology, 1st Faculty of Medicine, General University Hospital, Prague, Czech Republic

50. Department of Pathology, University of Toronto, Toronto, Ontario, Canada

51. Department of Pathology and Medical Biology, University of Groningen, Groningen, The Netherlands

52. Pathology Unit, Città della Salute e della Scienza di Torino University Hospital, Turin, Italy

53. Institute of Pathology, University Hospital of Cologne, Cologne, Germany

54. Department of Pathology, University of Utah, Salt Lake City, Utah

55. Department of Pathology, University of Kentucky Medical Center, Lexington, Kentucky

56. Department of Pathology, Mass General Brigham, Salem Hospital, Salem, Massachusetts

57. Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota

58. Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, California

59. Department of Pathology, The Jikei University School of Medicine, Tokyo, Japan

60. Department of Pathology, Washington University in Saint Louis, St. Louis, Missouri

61. Bambino Gesù Children's Hospital–IRCCS, Rome, Italy

62. Pathology Department, Bambino Gesù Children's Hospital, Rome, Italy

63. Pathology, University Oulu and Oulu University Hospital, Oulu, Finland

64. Pathology Section, Department of Public Health, School of Medicine, University of Naples Federico II, Naples, Italy

65. Medical Center-University of Freiburg and Faculty of Medicine, Institute for Surgical Pathology, University of Freiburg, Freiburg, Germany

66. Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland

67. Department of Pathology, AP-HP, Hôpital Bichat, Université Paris Cité, Paris, France

68. Laboratory of Electron Microscopy, Pathological Center, Peking University First Hospital, Beijing, China

Abstract

Background Nephritis is a common manifestation of IgA vasculitis and is morphologically indistinguishable from IgA nephropathy. While MEST-C scores are predictive of kidney outcomes in IgA nephropathy, their value in IgA vasculitis nephritis has not been investigated in large multiethnic cohorts. Methods Biopsies from 262 children and 99 adults with IgA vasculitis nephritis (N=361) from 23 centers in North America, Europe, and Asia were independently scored by three pathologists. MEST-C scores were assessed for correlation with eGFR/proteinuria at biopsy. Because most patients (N=309, 86%) received immunosuppression, risk factors for outcomes were evaluated in this group using latent class mixed models to identify classes of eGFR trajectories over a median follow-up of 2.7 years (interquartile range, 1.2–5.1). Clinical and histologic parameters associated with each class were determined using logistic regression. Results M, E, T, and C scores were correlated with either eGFR or proteinuria at biopsy. Two classes were identified by latent class mixed model, one with initial improvement in eGFR followed by a late decline (class 1, N=91) and another with stable eGFR (class 2, N=218). Class 1 was associated with a higher risk of an established kidney outcome (time to ≥30% decline in eGFR or kidney failure; hazard ratio, 5.84; 95% confidence interval, 2.37 to 14.4). Among MEST-C scores, only E1 was associated with class 1 by multivariable analysis. Other factors associated with class 1 were age 18 years and younger, male sex, lower eGFR at biopsy, and extrarenal noncutaneous disease. Fibrous crescents without active changes were associated with class 2. Conclusions Kidney outcome in patients with biopsied IgA vasculitis nephritis treated with immunosuppression was determined by clinical risk factors and endocapillary hypercellularity (E1) and fibrous crescents, which are features that are not part of the International Study of Diseases of Children classification.

Funder

Cedars-Sinai Medical Center

Publisher

Ovid Technologies (Wolters Kluwer Health)

Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3